0001225208-15-007464.txt : 20150310 0001225208-15-007464.hdr.sgml : 20150310 20150310175240 ACCESSION NUMBER: 0001225208-15-007464 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150306 FILED AS OF DATE: 20150310 DATE AS OF CHANGE: 20150310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CIGNA CORP CENTRAL INDEX KEY: 0000701221 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 061059331 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20111019 FORMER COMPANY: FORMER CONFORMED NAME: CIGNA CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Manders Matthew G CENTRAL INDEX KEY: 0001480601 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08323 FILM NUMBER: 15690372 MAIL ADDRESS: STREET 1: 1601 CHESTNUT STREET STREET 2: TWO LIBERTY PLACE CITY: PHILADELPHIA STATE: PA ZIP: 19192 4 1 doc4.xml X0306 4 2015-03-06 0000701221 CIGNA CORP CI 0001480601 Manders Matthew G 900 COTTAGE GROVE ROAD BLOOMFIELD CT 06002 1 Pres. US Comm Mkts & Gbl HC Op Common Stock, $.25 Par Value 2015-03-06 4 S 0 15263.0000 120.9518 D 50827.0000 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2014. Represents the weighted average price of the shares sold. The prices actually received ranged from $120.67 to $121.24 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Exhibit List: Exhibit Ex-24 - Power of Attorney, manderspoa.txt By: Amy Rhoades, attorney-in-fact 2015-03-10 EX-24 2 manderspoa.txt POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, an officer of Cigna Corporation, a Delaware corporation ("Cigna"), hereby makes, designates, constitutes and appoints NICOLE S. JONES, NEIL BOYDEN TANNER, AMY RHOADES, JILL STADELMAN, and MARGUERITE GEIGER each acting individually, as the undersigned's true and lawful attorneys-in-fact and agents, with full power and authority to act in the undersigned's capacity as an officer of Cigna for and in the name, place and stead of the undersigned in connection with the filing with the Securities and Exchange Commission pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934, both as amended, of the execution and delivery of Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, Forms 144 in accordance with Rule 144 promulgated under the Securities Act of 1933 and any and all other documents related thereto (including, but not limited to, Seller's Representation Letters) and to take further action as they, or any of them, deem appropriate in connection with the foregoing. Such attorneys-in-fact and agents, or any of them, are also hereby granted full power and authority, on behalf of and in the name, place and stead of the undersigned, to execute and deliver all such amendments, qualifications and notifications; to execute and deliver any and all such other documents; and to take further action as they, or any of them, deem appropriate in connection with the foregoing. The powers and authorities granted herein to such attorneys-in-fact and agents, and each of them, also include the full right, power and authority to effect necessary or appropriate substitutions or revocations. The undersigned hereby ratifies, confirms, and adopts, as his own act and deed, all action lawfully taken by such attorneys-in-fact and agents, or any of them, or by their respective substitutes, pursuant to the powers and authorities herein granted. This Power of Attorney shall remain in full force and effect until the undersigned no longer has responsibilities relating to Section 16 of the Securities Exchange Act of 1934 or Rule 144 promulgated under the Securities Act of 1933 with respect to the undersigned's beneficial ownership of securities of Cigna, unless earlier revoked by the undersigned in a signed writing to each such attorney in fact. IN WITNESS WHEREOF, the undersigned has executed this document as of the 5th day of January, 2015. /s/Matthew G. Manders Signature Matthew G. Manders Print Name